The largest database of trusted experimental protocols

P450 glo cyp3a4 assay with luciferin ipa

Manufactured by Promega
Sourced in United States

The P450-Glo™ CYP3A4 Assay with Luciferin-IPA is a luminescent-based assay used to measure the activity of the CYP3A4 enzyme. The assay uses a luciferin-based substrate, Luciferin-IPA, which is metabolized by CYP3A4, resulting in the generation of light. The amount of light produced is proportional to the CYP3A4 enzyme activity in the sample.

Automatically generated - may contain errors

8 protocols using p450 glo cyp3a4 assay with luciferin ipa

1

CYP3A4 Induction Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
CYP3A4 activity was measured using a P450-Glo™ CYP3A4 Assay with Luciferin-IPA (Promega Corporation), following the manufacturer's instructions. Luminescence was measured in duplicates using an ARVO MX (PerkinElmer, Inc.) plate reader. CYP3A4 activity values were corrected using total RNA amount values. Total RNA was extracted using an RNeasy micro kit (Qiagen) according to the manufacturer's instructions, from wells different from those used for the CYP assay on day 3, and was measured using NanoDrop 2000c (Thermo Fisher Scientific, Inc.). For the CYP3A4 induction assay, the culture medium was replaced with HCM containing 25 µM rifampicin (Sigma-Aldrich; Merck KGaA) in 0.1% dimethyl sulfoxide (DMSO) or vehicle control (0.1% DMSO alone) on day 1. rifampicin is the drug most commonly used to induce CYP3A enzyme activity. In addition, this induction route may be used by different medications, such as phenobarbital (24 (link)). On the following day, the medium was replaced with fresh medium containing the inducer or vehicle. After 48 h of treatment, CYP3A4 activity was measured as described above.
+ Open protocol
+ Expand
2

Silencing CYP3A4 in Primary Hepatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
ON-TARGETplus SMARTpool siRNA oligonucleotides (CYP3A4, catalog no. L-008169010005; nontargeting control pool, catalog no. D-001810–10-05; Dharmacon) were delivered to hepatocytes using RNAiMAX Transfection Reagent (Thermo Fisher Scientific) per the manufacturer’s protocols at final concentration of 100 nM in antibiotic-free media (final volume 100 μL). Triplicate wells containing mpPHH were exposed to siRNA duplexes overnight for 24 h and subsequently cultured in supplemented hepatocyte media. Knockdown efficiency was determined by qRT-PCR using specific CYP3A4 primers and using a cell-based P450-Glo CYP3A4 Assay with luciferin-IPA (catalog no. V9002; Promega) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
3

Comprehensive Airway and Liver MPS Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were taken from the platform modules 17, 24 and 48 hours after each medium change. CC10 production from airway tissue was measured by ELISA (R&D Systems, Minneapolis, MN) performed according to the manufacturer’s specifications. Comparisons to static airway models were made for on-platform airway models at the t=17hr time point only, pre-interaction. Total albumin from liver co-cultures was measured using a human albumin ELISA kit (Bethyl Labs, Montgomery, TX). At the termination of the experiment, CYP3A (Cytochrome P450 3A) function was assessed using the P450-GloCYP3A4 Assay with Luciferin-IPA (Promega, Madison, WI) by adding 2 mL of the luminogenic substrate (1:1000 in WEM maintenance medium) to each liver MPS and incubated at 37°C for 1 hour with self-circulating flow in the upwards direction. Tissue formation was assessed by staining for cell nuclei on scaffolds using Hoescht 33342 (Thermo Fisher, Waltham MA) diluted 1:1000 in WEM for 20 minutes. Following image analysis, scaffolds were incubated in RIPA buffer at 4°C then scraped to remove cells; total protein was measured using a BCA ELISA kit (Pierce). Human serum albumin (HSA) levels were normalized to the total amount of protein present.
+ Open protocol
+ Expand
4

Quantifying CYP3A4 Activity in Caco-2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure the CYP3A4 activity, the Lytic assay was performed by using a P450-Glo™ CYP3A4 Assay with Luciferin-IPA (Promega) according to the manufacturer’s instructions. The luminescence was read by a Lumat LB 9507 (Berthold Technologies). The CYP3A4 activity was normalized with the protein content per well, which was evaluated with the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific).
UPLC-MS/MS analysis was also performed to examine the CYP3A4 activity according to our previous report30 (link). Briefly, Caco-2 cells and their derivatives were cultured with medium containing 5 μM midazolam (MDZ, FUJIFILM Wako). After the treatment with MDZ, the supernatant was collected at 30 min, and then immediately mixed with two volumes of acetonitrile (FUJIFILM Wako). The supernatant was analyzed by UPLC-MS/MS to measure the concentrations of the metabolite, 1′-hydroxymidazolam (1′-OH MDZ), according to each standard followed by normalization to the protein content per well.
+ Open protocol
+ Expand
5

CYP450 Induction Assay in pHEALs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture supernatants were collected and stored at −20 °C. Albumin content was measured by an enzyme-linked immunosorbent assay using goat anti-human albumin antibody (Bethyl Labs) with horseradish peroxidase detection (Bethyl Labs) and 3,3′,5,5′-tetramethylbenzidine (TMB, Pierce) development. For CYP450 induction studies, in vitro p-HEALs were treated daily for 3 days with CYP450 inducer rifampin (20 μM). Subsequently, CYP3A4 activity was measured using the P450-Glo™ CYP3A4 Assay with Luciferin-IPA (Promega) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
6

Cytotoxicity and Metabolic Assessment of Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Materials used in the present study were obtained as follows: Dulbecco’s modified Eagle medium (DMEM), N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES), antibiotics (penicillin and streptomycin), and LIVE/DEAD Viability/Cytotoxicity kit were from Life Technologies Corp. (Grand Island, NY, USA); fetal bovine serum (FBS), Hanks’ balanced salt solution (HBSS), dimethyl sulfoxide (DMSO) and fluorescein diacetate (FD) from Sigma-Aldrich (St. Louis, MO, USA); Glucose C-II Test Wako and Urea nitrogen-B Test Wako from Wako Pure Chemical Industries (Osaka, Japan); Human Albumin ELISA Quantitation Set from Bethyl Laboratories (Montgomery, TX, USA); P450-Glo CYP3A4 Assay with Luciferin-IPA from Promega (Madison, WI, USA); Millicell from Merck Millipore (Darmstadt, Germany); all other materials and chemicals not specified above were of the highest grade.
+ Open protocol
+ Expand
7

Quantifying hPSC-Hep Albumin and CYP3A4

Check if the same lab product or an alternative is used in the 5 most similar protocols
Albumin production of hPSC‐Heps was measured using the Human Albumin Quantification Set (Bethyl Laboratories, Montgomery, AL). Culture medium supernatants were collected after 48 hours and stored at −20°C. Enzyme‐linked immunosorbent assay (ELISA) was carried out according to manufacturer's instructions. Absorbance was measured at 450 nm on a Promega GloMax Multi+ Detection System plate reader (Promega).
Native cytochrome P450 CYP3A4 activity was assessed using the CYP3A4 P450‐Glo Assay with Luciferin‐IPA (Promega). The bioluminescent substrate was incubated on hPSC‐Heps for 1 hour before being collected for analysis. Luminescence was measured using a Promega GloMax Discover multimode microplate reader (Promega).
+ Open protocol
+ Expand
8

CYP3A4 Activity Quantification in HeLa Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytochrome P450 (CYP) 3A4 activity was measured using the CYP3A4 P450-Glo™ assay (with Luciferin-IPA) (Promega) as previously described [13] (link). Briefly, HeLa cell lines were seeded at a density of 2×104 cells/well in 12-well plates (Sarstedt Inc.). Twenty-four hours later, 0.5 µg of CYPOR-YFP plasmid (kindly provided by Dr. Byron Kemper, University of Illinois, USA) was transfected into cells using Lipofectamine 2000 reagent (Life Technologies). Twenty-four hours after transfection, cells were washed with phosphate-buffered saline and fresh media containing luminogenic substrate (50 µM) was added. After a 3 h incubation period, 100 µl of media from each well was mixed with an equal volume of Luciferin Detection reagent and luminescence was measured using a LUMIstar luminometer (BMG LABTECH).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!